Pituitary apoplexy: A review of clinical presentation, management and outcome in 45 cases

被引:182
作者
Sibal L. [1 ]
Ball S.G. [1 ]
Connolly V. [2 ]
James R.A. [1 ]
Kane P. [3 ]
Kelly W.F. [2 ]
Kendall-Taylor P. [1 ]
Mathias D. [4 ]
Perros P. [1 ]
Quinton R. [1 ]
Vaidya B. [2 ,5 ]
机构
[1] Department of Endocrinology, Newcastle University Teaching Hospitals, Newcastle upon Tyne
[2] Department of Endocrinology, The James Cook University Hospital, Middlesbrough
[3] Department of Neurosurgery, The James Cook University Hospital, Middlesbrough
[4] Department of Otonasolaryngology, Newcastle University Teaching Hospitals, Newcastle upon Tyne
[5] Department of Endocrinology, Diabetes and Vascular Medicine, Peninsula Medical School, Royal Devon and Exeter Hospital
关键词
Hypopituitarism; Pituitary adenoma; Pituitary apoplexy; Visual loss;
D O I
10.1007/s11102-005-1050-3
中图分类号
学科分类号
摘要
Objective: To review clinical presentation, management and outcomes following different therapies in patients with pituitary apoplexy. Methods: Retrospective analysis of case-records of patients with classical pituitary apoplexy treated in our hospitals between 1983-2004. Results: Forty-five patients (28 men; mean age 49 years, range 16-72 years) were identified. Only 8 (18%) were known to have pituitary adenomas at presentation. Thirty-four (81%) patients had hypopituitarism at presentation. CT and MRI identified pituitary apoplexy in 28% and 91% cases, respectively. Twenty-seven (60%) patients underwent surgical decompression, whilst 18 (40%) were managed conservatively. Median time from presentation to surgery was 6 days (range 1-121 days). Patients with visual field defects were more likely than those without these signs to be managed surgically (p = 0.01). Complete or near-complete resolution occurred in 93% (13/14), 94% (15/16) and 93% (13/14) of the surgically treated patients with reduced visual acuity, visual field deficit and ocular palsy, respectively. All patients with reduced visual acuity (4/4), visual field deficit (4/4) and ocular palsy (8/8) in the conservative group had complete or near-complete recovery. Only 5 (19%) patients in the surgical group and 2 (11%) in the conservative group had normal pituitary function at follow up. One (4%) patient in the surgical group and 4 (22%) in the conservative group had a recurrence of pituitary adenoma. Conclusions: This large series suggests that the patients with classical pituitary apoplexy, who are without neuro-ophthalmic signs or exhibit mild and non-progressive signs, can be managed conservatively in the acute stage. © Springer Science + Business Media, Inc. 2005.
引用
收藏
页码:157 / 163
页数:6
相关论文
共 31 条
[1]  
Brougham M., Heusner A.P., Adams R.D., Acute degenerative changes in adenomas of the pituitary body - With special reference to pituitary apoplexy, J Neurosurg, 7, pp. 421-439, (1950)
[2]  
Rovit R.L., Fein J.M., Pituitary apoplexy: A review and reappraisal, J Neurosurg, 37, pp. 280-288, (1972)
[3]  
Cardoso E.R., Peterson E.W., Pituitary apoplexy: A review, Neurosurgery, 14, pp. 363-373, (1984)
[4]  
Reid R.L., Quigley M.E., Yen S.S., Pituitary apoplexy. A review, Arch Neurol, 42, pp. 712-719, (1985)
[5]  
McFadzean R.M., Doyle D., Rampling R., Teasdale E., Teasdale G., Pituitary apoplexy and its effect on vision, Neurosurgery, 29, pp. 669-675, (1991)
[6]  
Randeva H.S., Schoebel J., Byrne J., Esiri M., Adams C.B., Wass J.A., Classical pituitary apoplexy: Clinical features, management and outcome, Clin Endocrinol (Oxf), 51, pp. 181-188, (1999)
[7]  
Mohanty S., Tandon P.N., Banerji A.K., Prakash B., Haemorrhage into pituitary adenomas, J Neurol Neurosurg Psychiatry, 40, pp. 987-991, (1977)
[8]  
Mohr G., Hardy J., Hemorrhage, necrosis, and apoplexy in pituitary adenomas, Surg Neurol, 18, pp. 181-189, (1982)
[9]  
Epstein S., Pimstone B.L., De Villiers J.C., Jackson W.P., Pituitary apoplexy in five patients with pituitary tumours, Br Med J, 2, pp. 267-270, (1971)
[10]  
Ebersold M.J., Laws Jr. E.R., Scheithauer B.W., Randall R.V., Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study, J Neurosurg, 58, pp. 315-320, (1983)